Fitzgerald Kevin Joseph

EDGAR CIK 0001886431

Alnylam Pharmaceuticals, Inc. - ALNY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Officer
CSO & EVP, Head of Research
Direct Buys
0
$0
0 Shares
Direct Sells
7
($3.06) M
-9,191 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/02/2025
10/03/2025
Sell
-2,441 @ $452.05
 ($1,103,451) 25,231 (-8.82%) Direct
08/18/2025
08/19/2025
Sell
-1,396 @ $453.27
 ($632,759) 22,719 (-5.79%) Direct
03/04/2025
10b5-1
03/05/2025
Sell
-844 @ $241.15
 ($203,532) 13,501 (-5.88%) Direct
03/03/2025
10b5-1
03/05/2025
Sell
-1,911 @ $243.73
 ($465,772) 14,345 (-11.76%) Direct
02/28/2025
03/03/2025
Sell
-496 @ $241.69
 ($119,878) 12,385 (-3.85%) Direct
02/18/2025
10b5-1
02/18/2025
Sell
-1,440 @ $251.56
 ($362,243) 12,881 (-10.06%) Direct
02/14/2025
02/18/2025
Sell
-663 @ $255.21
 ($169,204) 14,321 (-4.42%) Direct